- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02149069
Blood Management Program in the Post - Operative Period.
July 31, 2015 updated by: PAMELABERNI, Arcispedale Santa Maria Nuova-IRCCS
Blood Management Program: Appropriateness of Transfusion Therapy in the Post - Operative Period.
A care path in the field of transfusion medicine was creates at ASMN - IRCCS addressed to patients undergoing complex surgical procedures.
Study Overview
Status
Unknown
Detailed Description
This pathway is called Blood Management Program (BMP).
The implementation of this process should improve transfusion therapy in the peri-operative period in order to:
- correct the transfusional approach to surgical patients
- optimize the management of transfusional resources (red blood cells, plasma, platelets)
- optimize the management of plasma derivatives, drugs and techniques designed to limit the use of homologous blood
Study Type
Observational
Enrollment (Anticipated)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Emilia Romagna
-
Reggio Emilia, Emilia Romagna, Italy, 42123
- Recruiting
- IRCCS-Arcispedale Santa Maria Nuova
-
Contact:
- Pamela Berni, Biology
- Phone Number: +39-0522-295057
- Email: pamela.berni@asmn.re.it
-
Principal Investigator:
- Di Bartolomeo Erminia, Physician
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
patients undergoing complex surgical procedures
Description
Inclusion Criteria:
-All patients undergoing complex surgical procedures
Exclusion Criteria:
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Evaluation of therapeutic appropriateness for Red Cells - Plasma - Platelets transfusion: comparison between prospective vs. retrospective data in ASMN ,Reggio Emilia (Italy)
Time Frame: 24 months
|
24 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Erminia Di Bartolomeo, MD, Asmn-Irccs
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2014
Primary Completion (Anticipated)
December 1, 2015
Study Completion (Anticipated)
January 1, 2016
Study Registration Dates
First Submitted
May 26, 2014
First Submitted That Met QC Criteria
May 28, 2014
First Posted (Estimate)
May 29, 2014
Study Record Updates
Last Update Posted (Estimate)
August 3, 2015
Last Update Submitted That Met QC Criteria
July 31, 2015
Last Verified
June 1, 2015
More Information
Terms related to this study
Other Study ID Numbers
- BMP - TRASFU1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Excessive Amount of Blood / Fluid Transfusion
-
Universita di VeronaCompletedExcessive Amount of Blood / Fluid TransfusionItaly
-
Meir Medical CenterUnknownExcessive Amount of Blood / Fluid TransfusionIsrael
-
Deutsches Herzzentrum MuenchenRecruitingHeart Failure | Anesthesia | Failed Conscious Sedation During Procedure | Critical Incident | Excessive Amount of Blood / Fluid Transfusion | Intraoperative Cardiac Arrest During Cardiac SurgeryGermany
-
Ente Ospedaliero Cantonale, BellinzonaCompletedHypotension and Shock | Excessive Amount of Blood / Fluid InfusionSwitzerland
-
Near East University, TurkeyCompletedthe Influence of Intra- vs Extra-abdominal Removal of Placenta | Duration of Operation | the Amount of Aspirated Fluid During the Operation | Difference Between Pre- and Post-operative CBCTurkey
-
AstraZenecaCompletedAmount of NKTR-118 in Blood | Variation in the Heart's Electrical CycleUnited States
-
Australian and New Zealand Intensive Care Research...University College Dublin; King Abdulaziz Medical City; Australian Red Cross; New... and other collaboratorsCompletedTransfusion | Age of BloodIreland, Australia, New Zealand, Finland, Saudi Arabia
-
AstraZenecaCompletedHealthy Volunteers | Pharmacokinetics | Hepatic Impairment | Amount of R406 in BloodUnited States
-
University of PennsylvaniaCompletedFocus of Study | Coagulation Status of Cardiac Surgery Patient | Reducing Excess Blood TransfusionUnited States
-
Università degli Studi di FerraraCompletedAnemia | Acute Kidney Injury | Fluid Overload | Transfusion-Associated Circulatory OverloadItaly